webinar register page

This webinar is for users with a Zoom account. New to Zoom? Sign up free.
Criterion-Referenced Testing and PAEA's End of Rotation™ Exams: A Focus on Scoring
End of Rotation™ exams are a set of objective standardized evaluations intended to serve as one measure of the medical knowledge students gain during specific supervised clinical practice experiences. More information is available here: https://paeaonline.org/assessment/end-of-rotation

This webinar will explain the purpose of the PAEA End of Rotation exams and provide an overview of scale scores. The material presented will help faculty develop an understanding of scale scoring and how to apply the scores appropriately to the program.

At the end of the webinar, participants will be able to:
* Describe the assessments that comprise a SCPE grade
* Review the intended purpose of End of Rotation exams and explain scaled scores
* Demonstrate how to interpret End of Rotation exams scores in the context of a student’s mastery of the relevant content knowledge

This session will be recorded and made available in the PAEA Digital Learning Hub for all members.

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 1/26/2023 to 1/26/2023. AAPA reference number: CME-208214.

A Zoom account is required to register and participate in this event. If you don't have one, you can sign up here for a free account: https://zoom.us/signup.

Jan 26, 2023 03:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information


Robert (Robbie) Furter
Robert (Robbie) Furter, PhD, is the senior director of assessment and psychometrician at PAEA, where he oversees PAEA’s suite of exam programs. His current work focuses on communicating the value of assessment and supporting educators in their use and interpretation of assessment scores. Robbie’s research interests include principled assessment design, the creation of robust assessment systems, and optimization across the assessment lifecycle. In addition to his work at PAEA, Robbie serves as a lecturer for the University of North Carolina at Greensboro.
Denise Rizzolo
Denise Rizzolo, PhD, MPH, PA-C, is an assessment and evaluation specialist for the PAEA. She received her master’s degree in Science – Physician Assistant from Rutgers University, her PhD in health science from Seton Hall University, and her MPH from the University of Missouri. Denise has an 18-year history in higher education, working with the Seton Hall University PA program for 16 of those years. Given her passion for public health, Denise has been a volunteer at the Westfield Regional Health Department where she first served as the communicable disease outreach coordinator and is now a COVID-19 advisor. She helps reach vulnerable populations by making house visits to administer the COVID-19 vaccine. Denise is focused on cultural humility in assessment and lectures and publishes on the topic regularly. She recently presented her work on cultural humility in item-writing to the Association of American Medical Colleges and to the American Board of Medical Examiners.
Olivia Ziegler
Olivia Ziegler, MS, PA, is PAEA’s chief assessment officer. In this role, she engages with the Board of Directors and senior leadership to develop and advance the Association’s mission and strategic priorities. In the area of assessment, she is responsible for implementing strategies to expand PAEA’s assessment products, ensuring they are responsive to the current and future needs of member programs. As an educator, Olivia was previously the director of clinical affairs at the University of Utah PA program and served as a site visitor for ARC-PA. Before joining the Utah faculty, she spent a decade in clinical practice where she played a founding role in building a new interprofessional palliative care service covering four hospitals. She has previously served on the boards of multiple organizations and as a grant reviewer for both HRSA and CMS. She has extensive experience with phase II IV drug trials and is the former executive director of a private clinical research organization.